YOU ARE HERE: LAT HomeCollectionsGlaucoma


June 18, 1990 | Reprinted from the July issue of The Johns Hopkins Medical Letter. and
"I haven't felt a thing, felt it at all." --President George Bush, after he learned he was at risk for glaucoma. If George Bush hadn't been President--and under the watchful care of his own personal physician--he might very well have not bothered to see an ophthalmologist since he hadn't "felt a thing."
April 26, 1990 | From Associated Press
Two prominent eye doctors confirmed Wednesday that President Bush has a mild form of glaucoma, but said he need not continue using prescription eye drops. "Extensive testing of the eye, including detailed photographs, once again revealed no abnormalities and no visual loss," said Dr. Burton Lee, the White House physician. "It was decided to stop the Betagan eye drops and follow him closely for now, on no treatment."
April 13, 1990 | From a Times Staff Writer
President Bush emerged from a five-hour health examination Thursday and pronounced himself "like a spring colt." White House doctor Burton Lee agreed that Bush is in excellent health, although the routine physical did turn up "an early glaucoma" in Bush's left eye. The diagnosis was made at Bethesda Naval Hospital outside Washington. Bush, 65, will be required to take eye drops daily for the ailment. Extensive tests showed no visual impairment.
April 12, 1990 | From Times Wire Services
President Bush is suffering from "an early glaucoma" in his left eye, medical tests disclosed today. The glaucoma, which the White House said has not affected his vision, was discovered during a routine physical at Bethesda Naval Hospital, the White House said. It will be treated with eyedrops. In general, Bush "is in excellent health," White House physician Dr. Burton Lee said in a statement released by the press office after the President's 5-hour examination.
June 18, 1989 | BRIAN MURPHY, Associated Press
Elvy Musikka begins most days as she ends them--smoking a legal joint and hoping others like her can some day do the same. Either rolled like a cigarette or baked into brownies, marijuana has been in Musikka's life for more than 12 years as she tried to lessen the effects of glaucoma, which has left her with only 10% of her sight. But she clearly sees herself as a crusader for the thousands of glaucoma victims throughout the United States denied legal use of the drug that reduces the high eye pressure caused by the disease.
November 29, 1987
Pacific Hospital of Long Beach offers three free screening clinics for the public as follows: A foot-screening clinic provides a licensed podiatrist to give examinations at 11 a.m. on the first and third Wednesday of every month. A simple test for glaucoma will be given by an ophthalmologist during a glaucoma screening clinic at 11 a.m. on the second Wednesday of every month.
March 29, 1987
Beginning this year, all children ages 5 and older who are claimed as dependents on tax returns will be required to have their own Social Security numbers, the Social Security Administration has announced. The SSA is working with local school districts to help elementary and junior high school students who need Social Security numbers get them, according to the Los Angeles County Office of Education.
February 3, 1986 | Sibyl Jefferson \f7
The La Palma Seniors Club, in cooperation with the National Society to Prevent Blindness, is offering a free glaucoma screening Thursday from 1 to 3 p.m. at the La Palma Community Center, 7821 Walker St. Glaucoma, a progressive eye disease that causes blindness with few or no symptoms, has been considered by experts to be the nation's leading cause of blindness. Early diagnosis and treatment can control glaucoma, but any loss of sight before treatment cannot be regained.
January 17, 1986 | ROBERT HANLEY
Allergan Pharmaceuticals Inc. said it has received federal Food and Drug Administration approval for a new eye drop for treatment of glaucoma. The Irvine-based company claims its product can save sufferers of the eye disease as much as 60% of the cost of the current leading eye drop treatment. Like other glaucoma drops, the new drug reduces pressure in the eye by inhibiting the production of fluid, said a spokeswoman for SmithKline Beckman Corp., Allergan's Philadelphia-based parent.
Los Angeles Times Articles